QuantRx Biomedical Corporation

OTCPK:QTXB Stock Report

Market Cap: US$314.8k

QuantRx Biomedical Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on QuantRx Biomedical's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Sep 2022

Recent past performance updates

No updates

Recent updates

In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, QuantRx Biomedical has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.

Show section

Revenue & Expenses Breakdown
Beta

How QuantRx Biomedical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:QTXB Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 220000
30 Jun 220000
31 Mar 220000
31 Dec 210000
30 Sep 210000
30 Jun 210000
31 Mar 210000
31 Dec 200000
30 Sep 200-100
30 Jun 200-100
31 Mar 200-100
31 Dec 190-100
30 Sep 190-100
30 Jun 190-100
31 Mar 190-100
31 Dec 180-100
30 Sep 180100
30 Jun 180100
31 Mar 180100
31 Dec 170100
30 Sep 170000
30 Jun 170000
31 Mar 170000
31 Dec 160000
30 Sep 160000
30 Jun 160000
31 Mar 160000
31 Dec 150000
30 Sep 150-100
30 Jun 150-100
31 Mar 150-100
31 Dec 140-100
30 Sep 140-100
30 Jun 140-100
31 Mar 140-100
31 Dec 130000
30 Sep 130000
30 Jun 130000

Quality Earnings: Insufficient data to determine if QTXB has high quality earnings.

Growing Profit Margin: Insufficient data to determine if QTXB's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if QTXB's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare QTXB's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if QTXB's earnings growth over the past year exceeded the Medical Equipment industry average.


Return on Equity

High ROE: QTXB has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.